(Q24297730)

GOA release 2020-03-11

author name string

S A van Gool

1

0 references

G A Kamp

2

0 references

R J Odink

3

0 references

S M P F de Muinck Keizer-Schrama

4

0 references

H A Delemarre-van de Waal

5

0 references

W Oostdijk

6

0 references

J M Wit

European Journal of Endocrinology

7

0 references

language of work or name

English

0 references

publication date

April 2010

0 references

published in

0 references

volume

162

0 references

page(s)

653-60

0 references

issue

4

0 references

cites work

Stage line diagram: an age-conditional reference diagram for tracking development

1 reference

https://api.crossref.org/works/10.1530%2FEJE-09-0880

7 January 2021

Height, weight, body mass index and pubertal development reference values for children of Turkish origin in the Netherlands.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-09-0880

7 January 2021

Idiopathic short stature: management and growth hormone treatment

1 reference

https://api.crossref.org/works/10.1530%2FEJE-09-0880

7 January 2021

Idiopathic short stature: definition, epidemiology, and diagnostic evaluation.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-09-0880

7 January 2021

Near normalization of adolescent height with growth hormone therapy in very short children without growth hormone deficiency.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-09-0880

7 January 2021

Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-09-0880

7 January 2021

Intrauterine growth of live-born Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation

1 reference

https://api.crossref.org/works/10.1530%2FEJE-09-0880

7 January 2021

A new diagnostic workflow for patients with mental retardation and/or multiple congenital abnormalities: test arrays first

1 reference

https://api.crossref.org/works/10.1530%2FEJE-09-0880

7 January 2021

Skin fibroblasts of children with idiopathic short stature show an increased mitogenic response to IGF-I and secrete more IGFBP-3.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-09-0880

7 January 2021

Biochemical markers of growth hormone (GH) sensitivity in children with idiopathic short stature: individual capacity of IGF-I generation after high-dose GH treatment determines the growth response to GH

1 reference

https://api.crossref.org/works/10.1530%2FEJE-09-0880

7 January 2021

Nationwide age references for sitting height, leg length, and sitting height/height ratio, and their diagnostic value for disproportionate growth disorders.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-09-0880

7 January 2021

Spontaneous growth in idiopathic short stature. European Study Group

1 reference

https://api.crossref.org/works/10.1530%2FEJE-09-0880

7 January 2021

High dose growth hormone treatment induces acceleration of skeletal maturation and an earlier onset of puberty in children with idiopathic short stature

1 reference

https://api.crossref.org/works/10.1530%2FEJE-09-0880

7 January 2021

The calculation of target height reconsidered

1 reference

https://api.crossref.org/works/10.1530%2FEJE-09-0880

7 January 2021

Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-09-0880

7 January 2021

Final height in a large cohort of Dutch patients with growth hormone deficiency treated with growth hormone. Dutch Growth Hormone Working Group.

1 reference

https://api.crossref.org/works/10.1530%2FEJE-09-0880

7 January 2021

Continuing Positive Secular Growth Change in the Netherlands 1955–1997

1 reference

https://api.crossref.org/works/10.1530%2FEJE-09-0880

7 January 2021

Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment

1 reference

https://api.crossref.org/works/10.1530%2FEJE-09-0880

7 January 2021

Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Wor

1 reference

https://api.crossref.org/works/10.1530%2FEJE-09-0880

7 January 2021

Dose-dependent effect of growth hormone on final height in children with short stature without growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1530%2FEJE-09-0880

7 January 2021

Final height gain by GH therapy in children with idiopathic short stature is dose dependent

1 reference

https://api.crossref.org/works/10.1530%2FEJE-09-0880

7 January 2021

Pubertal growth and final height in hypopituitary boys: a minor role of bone age at onset of puberty

1 reference

https://api.crossref.org/works/10.1530%2FEJE-09-0880

7 January 2021

The metabolic clearance rate, serum half-time and apparent distribution space of authentic biosynthetic human growth hormone in growth hormone-deficient patients

1 reference

https://api.crossref.org/works/10.1530%2FEJE-09-0880

7 January 2021

release_wslkrmu2pvbmlnmmzy3bfwcetm

Identifiers

DOI

10.1530/EJE-09-0880

0 references

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wslkrmu2pvbmlnmmzy3bfwcetm

24 November 2022